Dr Reddys Laboratories Ltd Share Price Today, Live NSE/BSE Updates

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open1,274.5

High1,285

Low1,257

Prev. Close1,270.3

Avg. Traded Price1,273.87

Volume19,68,821

MARKET DEPTH

Total bid0.00

Total ask5,634.00

Orders	Qty	Bid
0	0	0
0	0	0
0	0	0
0	0	0
0	0	0

Ask	Qty	Orders
1270.3	6	5634
0	0	0
0	0	0
0	0	0
0	0	0

HIGH/LOW

52w

LOW/HIGH

₹1,257.0018 hours ago

₹1,285.0016 hours ago

LOWER/UPPER CIRCUITS

₹1,162.90

₹1,421.30

Dr Reddys Laboratories Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Annual Revenue,rose 16.73%, in the last year to ₹33,741.2 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.

Annual Net Profit,rose 1.38% in the last year to ₹5,655.1 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.

Price to Earning Ratio,is 18.98, lower than its sector PE ratio of 44.81.

LONG-TERM PRICE ANALYSIS

Stock return5Y CAGR : 17.24%

Net profit growth 5Y CAGR : 23.89%

STOCK RETURNS

Versus Nifty 50

1 w

+3.82%

-1.52%

1 mth

+0.32%

-3.28%

3 mth

+9.47%

+1.42%

6 mth

+8.99%

+6.55%

1 yr

-5.89%

-0.62%

3 yr

+57.37%

+43.84%

5 yr

+49.62%

+120.31%

Dr Reddys Laboratories Ltd Top mutual funds holding

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

3Y Return+29.5%

NAV₹41.47

UTI Healthcare Fund-Reg(IDCW)

3Y Return+26.6%

NAV₹231.64

Similar stocks

SUNPHARMA₹1,706.70-27.10 (1.56%)

DIVISLAB₹6,595.50-54.50 (0.82%)

TORNTPHARM₹3,741.90+11.30 (0.30%)

CIPLA₹1,554.60-4.80 (0.31%)

MANKIND₹2,567.20-8.30 (0.32%)

Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Grow your wealth with more research recommendations

+91

To visit the old Ventura website, click here.

Ventura Wealth Clients Login here